Product Information
VERQUVO 2.5 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $22.7445 per EA under NDC 00006502804. Its NADAC has been published 197 times since Sep 21, 2022.
Strength
2.5 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006502804
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERICIGUATApproval Type
New Drug (NDA)
FDA Application
NDA214377On Market Since
2/1/2021
Pharmacological Classes
Price Statistics
The NADAC for VERQUVO 2.5 MG TABLET has been published 197 times since Sep 21, 2022, and over the history we have for it it has risen 14.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.7445 per EA |
|---|---|
| All-time high | $22.7641 (Jun 10, 2026) |
| All-time low | $19.8405 (Sep 21, 2022) |
| 52-week high | $22.7641 |
| 52-week low | $22.1311 |
| Median price | $21.5598 |
| Average price | $21.4188 |
| Largest weekly change | +5.0% (Jan 18, 2023) |
| Weeks tracked | 197 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERQUVO 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERQUVO 2.5 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $22.7445 per EA (NDC 00006502804), effective Jun 24, 2026.
How has the price of VERQUVO 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERQUVO 2.5 MG TABLET has risen 14.6%. It has been tracked across 197 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for VERQUVO 2.5 MG TABLET?
Since Sep 21, 2022, the NADAC for VERQUVO 2.5 MG TABLET has ranged from a low of $19.8405 (Sep 21, 2022) to a high of $22.7641 (Jun 10, 2026), with a median of $21.5598 per EA.
Are there cheaper alternatives to VERQUVO 2.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VERQUVO 2.5 MG TABLET, but none are currently priced below it.
Who manufactures VERQUVO 2.5 MG TABLET?
VERQUVO 2.5 MG TABLET (NDC 00006502804) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification